Keywords: کپسیتابین; Oral chemotherapy; Capecitabine; Adverse drug reactions; Serious adverse events; Korea institute of drug safety and risk management; Korean adverse event reporting system database;
مقالات ISI کپسیتابین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کپسیتابین; Capecitabine; 5â²-Deoxy-5-fluorocytidine; 5â²-Deoxy-5-fluorouridine; 5-Fluorouracil; Chronomodulated chemotherapy; Chronopharmacokinetics;
Keywords: کپسیتابین; Colorectal cancer; Oxaliplatin; Capecitabine; 5-fluorouracil; Safety profile; Tolerability;
Keywords: کپسیتابین; 5-FU; 5-fluorouracil; BNP; brain natriuretic peptide; CK; creatinine phosphokinases; CK-MB; creatinine phosphokinases-myocardial band; CV; cardiovascular; DYPD; dihydropyrimidine dehydrogenase; ECG; electrocardiography; EF; ejection fraction; FAC; fluoroa
Keywords: کپسیتابین; 5-fluorouracil; imiquimod; ingenol mebutate; acitretin; American Joint Commission on Cancer; Brigham and Women's Hospital staging system; capecitabine; CDKN2A; cetuximab; chemotherapy; classification; cSCC; CT; cutaneous squamous cell carcinoma; familial
Keywords: کپسیتابین; Thymidine phosphorylase; Thymidine catabolism; Angiogenesis; 2-deoxy-d-ribose; ROS; NF-κB; 5-FU; Capecitabine; TFTD; 2-deoxy-d-ribose-5-phosphate aldolase; Glycolytic pathway;
Keywords: کپسیتابین; Capecitabine; Solubility; Correlation; Apparent thermodynamic characteristics;
Keywords: کپسیتابین; Capecitabine; FOLFIRI; FOLFOX; mCC; Outcomes;
Keywords: کپسیتابین; Capecitabine; Hand-foot-syndrome (HFS); Keratinocyte; Mitochondrial apoptosis;
Keywords: کپسیتابین; Breast cancer; Adjuvant chemotherapy; Capecitabine; Triple negative; Meta-analysis; RCTs;
Keywords: کپسیتابین; Colorectal; Cancer; Cost-effectiveness; Capecitabine; Bevacizumab;
Keywords: کپسیتابین; Drug conjugate; Capecitabine; Camptothecin; Drug delivery; Chemotherapy;
Keywords: کپسیتابین; adjuvant; capecitabine; FOLFIRINOX; gemcitabine; liposomal irinotecan metastatic; nab-paclitaxel; pancreatic cancer;
Keywords: کپسیتابین; Gastric cancer; D2 resection; Adjuvant chemotherapy; S-1; Capecitabine; Cisplatin; Oxaliplatin; Infusional 5-FU;
Keywords: کپسیتابین; Aspirin; Capecitabine; Chemotherapy; Colon cancer; Salvage treatment;
Keywords: کپسیتابین; Adenocarcinoma; Capecitabine; Erlotinib; Gemcitabine; Nab-paclitaxel; Oxaliplatin; Pancreas; Pneumonitis;
Keywords: کپسیتابین; Survival analysis; Breast cancer; Gemcitabine; Paclitaxel; Docetaxel; Capecitabine; Mathematical model; Treatment outcome; Response evaluation criteria in solid tumours;
Keywords: کپسیتابین; Fluoropyrimidine-associated toxicity; Capecitabine; Safety; adverse events; Toxicity;
Keywords: کپسیتابین; Capecitabine; 5-Fluorouracil; DPYD; Dihydropyrimidine dehydrogenase; Fluoropyrimidines; Toxicity; Personalized medicine; Pharmacogenetics
Keywords: کپسیتابین; Genetic polymorphisms; Capecitabine; Toxicity; Efficacy
Keywords: کپسیتابین; Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Keywords: کپسیتابین; eribulin; capecitabine; gemcitabine; metastatic breast cancer; triple negative; vinorelbine;
Keywords: کپسیتابین; Colorectal cancer; Gastroretentive drug delivery system; Capecitabine; Mucoadhesion; Texture profile analysis
Keywords: کپسیتابین; Capecitabine; CNS-toxicity; Encephalopathy; Chemotherapy
Keywords: کپسیتابین; Capecitabine; CTX; Colorectal cancer; Metronomic chemotherapy; Anti-angiogenesis
Keywords: کپسیتابین; Capecitabine; Dissolution; Amorphous; Spray drying; Slow release; Recrystallization;
Keywords: کپسیتابین; Biliary tract cancer; Gemcitabine; Capecitabine; Cetuximab;
Keywords: کپسیتابین; 5-fluorouracil; Cardiotoxicity; Capecitabine; Systematic review;
Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients
Keywords: کپسیتابین; Capecitabine; Colon cancer; Costimulatory molecule; microRNA; Single nucleotide polymorphism;
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial
Keywords: کپسیتابین; Geriatric assessment; Biomarker; Metastatic breast cancer; Prognostic factor; Pegylated liposomal doxorubicin; Anthracycline; Capecitabine; Elderly;
Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency
Keywords: کپسیتابین; Uridine triacetate; Fluorouracil; Capecitabine; Overdose; DPD;
TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy
Keywords: کپسیتابین; Breast cancer; Capecitabine; TYMS;
Theoretical prediction of chloroform, ethanol, water and DMSO effects on electronic characteristics of Capecitabine different conformers as an anticancer chemotherapy drug
Keywords: کپسیتابین; Capecitabine; Solvent effect; Density functional theory; Breast cancer; Chemotherapy drug;
Eudragit encapsulated cationic poly (lactic-co-glycolic acid) nanoparticles in targeted delivery of capecitabine for augmented colon carcinoma therapy
Keywords: کپسیتابین; Cancer; Colon carcinoma; Capecitabine; Drug delivery; Poly(lactic-co-glycolic acid); Eudragit® S100; Full factorial design; Nanoparticles;
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
Keywords: کپسیتابین; 5â²DFCR; 5â²deoxy-5-fluorocytidine; 5â²DFUR; 5â²-deoxy-5-fluorouridine; 5-FU; 5-fluorouracil; AEs; adverse events; AML; acute promyelocytic leukemia; AU; arbitrary unit; CDA; cytidine deaminase; CES; carboxylesterase; DPD; dihydropyrimidine dehydrogen
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer
Keywords: کپسیتابین; Breast cancer; Buparlisib; Capecitabine; PI3K; Phase I;
Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation
Keywords: کپسیتابین; Chitosan derivatives; Colon targeting; Colon cancer; Capecitabine; Chitosan succinate;
A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report
Keywords: کپسیتابین; Capecitabine; Secondary long QT syndrome; Ventricular fibrillation;
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine
Keywords: کپسیتابین; Capecitabine; Oral adjuvant chemotherapy; Stage III colon cancer; Tegafur plus leucovorin; UFT/LV;
Original ResearchIncidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
Keywords: کپسیتابین; Capecitabine; Cardiotoxicity; Retrospective analysis;
ReviewThe efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
Keywords: کپسیتابین; Breast cancer; Brain metastasis; Lapatinib; Capecitabine; Response rate; Review;
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer - Results from the prospective German TMK cohort study
Keywords: کپسیتابین; Breast neoplasms; Cohort studies; Palliative care; Outpatients; Real-world data; Registries; ABC; advanced breast cancer; AGO; Arbeitsgemeinschaft Gynäkologische Onkologie; Bev; bevacizumab; C; cyclophosphamid; Cap; capecitabine; Car; carboplatin; CCI; C
Original ResearchGemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborativ
Keywords: کپسیتابین; Gemcitabine; Erlotinib; Capecitabine; First-line; Metastatic pancreatic cancer;
Original StudyFinal Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer
Keywords: کپسیتابین; Capecitabine; Combination chemotherapy; Oral chemotherapy; Oral vinorelbine; Taxane doublet;
Functionally modified polyacrylamide-graft-gum karaya pH-sensitive spray dried microspheres for colon targeting of an anti-cancer drug
Keywords: کپسیتابین; Colon targeting; pH-sensitive graft copolymer; Gum karaya; Spray drying; Capecitabine;
Capillary electrophoresis with online stacking in combination with AgNPs@MCM-41 reinforced hollow fiber solid-liquid phase microextraction for quantitative analysis of Capecitabine and its main metabolite 5-Fluorouracil in plasma samples isolated from can
Keywords: کپسیتابین; AgNPs; Ag nanoparticles; CAP; Capecitabine; 5-FU; 5-Fluorouracil; TP; Thymidine phosphorylase; CE; Capillary electrophoresis; 5-FUH2; Dihydro-5-fluorouracil; FBAL; α-Fluoro-β-alanine; FUPA; 5-Fluoro-ureido-propionic acid; FLC; Fluoropyrimidine carbamate
Comparison of 5-FU-based and Capecitabine-based Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Meta-analysis
Keywords: کپسیتابین; Capecitabine; 5-fluorouracil; Pathologic complete response; Rectal cancer; Tumor down-staging;
The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: AÂ Longitudinal Study
Keywords: کپسیتابین; Capecitabine; Neuropathy; Numbness; Oxaliplatin; Tingling;
Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing
Keywords: کپسیتابین; Dihydropyrimidine dehydrogenase; DPYD; 5-Fluorouracil; Capecitabine; Pharmacogenetics; Toxicity;
The telomere-binding protein TRF2 is required for metronomic therapeutic effects of gemcitabine and capecitabine
Keywords: کپسیتابین; GEM; gemcitabine; CAP; capecitabine; TRF; telomere restriction fragment; TRF2; Telomere; Metronomic chemotherapy;